Gamma/Delta T-Lymphocyte
Curtain Closes on Takeda’s Cell Therapy Efforts
Takeda; cell therapy; research discontinuation; impairment loss; gamma delta T-cell; strategic shift; biopharmaceuticals
Actionable Insights Powered by AI
Takeda; cell therapy; research discontinuation; impairment loss; gamma delta T-cell; strategic shift; biopharmaceuticals